Reported Reactions

Devices › Device types

FDA product code NCX · class 2 · Cardiovascular

System, hypothermia, intravenous, cooling: medical device reports filed with FDA

4,407 reports carry this product code, 2005–2026; 6 brands with a page.

4,407
reports with this product code
0% of all MAUDE reports
277
reports, 12 months to August 2026
278 in the 12 months before
92.9%
classified as malfunction
62.3% across all reports
1%
classified as death, as reported
0.9% across all reports

Product code NCX is FDA's classification for "System, hypothermia, intravenous, cooling" (cardiovascular panel), a class 2 device. 4,407 medical device reports carry this product code, 0% of the MAUDE database, from June 2005 to August 2026.

277 reports arrived in the 12 months to August 2026, close to the 278 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (92.9%), injury (5.9%) and death (1%). 6 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Brands with this product code

BrandReportsLatest 12 monthsClassified as deathClassified as malfunction
Zoll Ivtm Thermogard Xp2,23800.1%99.7%
Zoll Ivtm Icy Catheter42901.9%90%
Zoll Ivtm Quattro Catheter39904.8%76.2%
Thermogard XP3311630%100%
Zoll Ivtm Solex 7 Catheter19502.1%85.6%
Invisalign System100%0%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Manufacturers named

Manufacturer (as written on reports)ReportsShare
Zoll Circulation4,34498.6%
Zoll Medical90.2%

Reports by month, five years

03365Sep 2021: 40Oct 2021: 30Nov 2021: 50Dec 2021: 492022Jan 2022: 27Feb 2022: 34Mar 2022: 44Apr 2022: 42May 2022: 40Jun 2022: 65Jul 2022: 44Aug 2022: 58Sep 2022: 39Oct 2022: 44Nov 2022: 35Dec 2022: 392023Jan 2023: 29Feb 2023: 33Mar 2023: 40Apr 2023: 21May 2023: 37Jun 2023: 28Jul 2023: 33Aug 2023: 43Sep 2023: 29Oct 2023: 29Nov 2023: 26Dec 2023: 252024Jan 2024: 26Feb 2024: 26Mar 2024: 32Apr 2024: 30May 2024: 27Jun 2024: 30Jul 2024: 22Aug 2024: 38Sep 2024: 33Oct 2024: 32Nov 2024: 25Dec 2024: 222025Jan 2025: 26Feb 2025: 25Mar 2025: 27Apr 2025: 23May 2025: 18Jun 2025: 9Jul 2025: 19Aug 2025: 19Sep 2025: 28Oct 2025: 25Nov 2025: 25Dec 2025: 322026Jan 2026: 19Feb 2026: 20Mar 2026: 16Apr 2026: 25May 2026: 15Jun 2026: 20Jul 2026: 34Aug 2026: 18

FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

Event type and report source

Event type

Death1%44
Injury5.9%261
Malfunction92.9%4,093
Other0%2
Not given0.2%7

Who filed

Manufacturer report96.9%4,272
Voluntary report1.2%51
User facility report0%0
Distributor report0%0
Not given1.9%84

Grey bar: all 26,136,888 MAUDE reports.

Device problems coded

Device problem (FDA code)ReportsShare
Visual prompts will not clear1,60636.4%
Fluid/blood leak78217.7%
Material integrity problema problem with the device material74616.9%
Device operates differently than expectedthe device behaved unexpectedly51811.8%
Device displays incorrect message4159.4%
Leak/splashthe device leaked2445.5%
Device issuea problem with the device1393.2%
Insufficient cooling791.8%
Temperature problem731.7%
Failure to power up671.5%
Unexpected shutdown591.3%
Device operational issue521.2%
Insufficient heating461%
Difficult to removethe device was hard to remove431%
No display/image400.9%
Difficult to advance290.7%
Noise, audible240.5%
Insufficient device problem information220.5%
Difficult to insertthe device was hard to insert200.5%
Power problem180.4%

Questions about system, hypothermia, intravenous, cooling reports

What is product code NCX?

FDA's classification code for "System, hypothermia, intravenous, cooling", class 2, reviewed by the cardiovascular panel. Every device report carries the product code of the device involved.

How many reports carry this code?

4,407 reports through August 2026, 277 of them in the latest 12 months.

Which brands appear most often?

Zoll Ivtm Thermogard Xp (2,238), Zoll Ivtm Icy Catheter (429), Zoll Ivtm Quattro Catheter (399), Thermogard XP (331) and Zoll Ivtm Solex 7 Catheter (195). Widely used products collect more reports because more people use them.

Can the brands table be used to rank the devices?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.